Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Feature Articles

Interdisciplinary Team Care for Diabetic Patients by Primary Care Physicians, Advanced Practice Nurses, and Clinical Pharmacists

  1. David Willens, MD,
  2. Rebecca Cripps, PharmD,
  3. Amy Wilson, PharmD,
  4. Kathleen Wolff, MSN, APRN, BC-FNP and
  5. Russell Rothman, MD, MPP
Clinical Diabetes 2011 Apr; 29(2): 60-68. https://doi.org/10.2337/diaclin.29.2.60
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

IN BRIEF

Most diabetic patients are managed by primary care physicians, but clinical inertia and limited time with patients hamper efforts to meet treatment goals. Successfully caring for the medical and psychosocial needs of the expanding diabetic population seen in primary care will require new strategies. This article reviews interdisciplinary efforts by primary care physicians, advanced practice nurses, and clinical pharmacists that can achieve improvements in clinical processes and outcomes at reasonable costs.

More than 23 million people in the United States have diabetes,1 and projections show that this number will increase to 48.3 million by 2050.2 Many of these patients will seek care in primary care clinics that are currently ill-equipped to address the rising demand.

Large studies such as the Diabetes Control and Complications Trial (DCCT), the U.K. Prospective Diabetes Study, and multiple studies on cardiovascular risk reduction have shown that improved glycemic, blood pressure, and cholesterol control can substantially reduce the risk of complications from diabetes.3–5 The American Diabetes Association has developed evidence-based process and outcome recommendations to meet these metabolic and cardiovascular goals.6 However, these guidelines have not been routinely met.7–10

Primary care practices are the main source of health care for most diabetic patients, but providers in these clinics face significant challenges in meeting the medical and psychosocial needs of this population. Long intervals between patient visits and limited time with patients can result in clinical inertia (the lack of timely treatment and intensification of therapy).11–13 The medical, educational, and psychosocial needs of diabetic patients are often complex and cannot always be adequately addressed in infrequent short visits with a single provider.

These difficulties were illustrated in a study of an electronic system that reminded clinicians of needed diabetes care during each visit.14 Even a well-designed system change was unable to substantially improve diabetes care. The processes had been previously agreed on by the providers, but even with this customized care plan in a motivated group, the physicians carried out only about one-third of the electronic reminders. They cited time constraints and other competing patient problems as barriers.

With the rising prevalence of diabetes, overcoming these issues will become even more challenging. Additional resources will be needed to meet the rising demand and to overcome barriers that primary care physicians face in the current health care system.15 Nurses and clinical pharmacists are increasingly joining with physicians in care teams to more successfully care for diabetic patients.

A recent Institute of Medicine report16 calls for expanding the role of nurses into areas such as care coordination and basic primary care delivery. Indeed, evidence from many studies shows that nurse practitioners can provide care for simple acute illnesses and routine chronic disease management with outcomes similar to primary care physicians.17 A large, well-known trial of community clinical pharmacists working collaboratively with primary care physicians to care for diabetic patients has shown improvements in clinical outcomes at reasonable cost.18–20 Nurse or pharmacist case management consisting of patient education, patient and family counseling, and close monitoring of health outcomes in conjunction with a physician has also been shown to improve outcomes for chronic illness,21,22 especially for diabetic patients.22–33 Notably, nurse case management was an integral part of intensive therapy in the DCCT.3 Team-based care has the potential to meet the complex needs of many diabetic patients.

A variety of quality improvement interventions, including the addition of mid-level providers, have been studied to improve diabetes care in the primary care setting. In general, these involve redistributing responsibilities to nurse or pharmacist providers, implementing new electronic tools, or facilitating communication and data exchange among patients and providers.

Table 1 describes programs that may fit well into primary care practices. Most are implemented within multifaceted programs involving more than one strategy. Although the results of studies have been varied,15 those involving team-based care and case management seem to be the most efficacious.32 Because each clinic has its own culture and patient needs, the suitability and results of each intervention will vary by location.

As described in Table 2, a number of systematic reviews and meta-analyses have summarized the research on nurse- and pharmacist-involved diabetes care to date.9,27,32–37 The interventions commonly included were patient education, case management, and medication management. Most of the programs showed promising results with significant improvements in glycemic control. The four meta-analyses each demonstrated pooled effects on A1C favoring nurse or pharmacist involvement.32–35 Also, several review articles reported improvements in blood pressure and cholesterol measurements, although the results were often inconsistent between studies.34–37 A breadth of evidence supports the use of strategies that allow pharmacists and nurses to join with physicians to expand the capacity to care for diabetic patients.

Many models exemplify team and process structures that can support nurses or pharmacists in partnership with primary care physicians. To successfully manage diabetes, patients may need more contact with the care team than a single primary care physician can provide. Additional visits and care coordination by other providers is one solution that has been studied. The following section highlights two successful models that have been implemented and rigorously evaluated.

Case Studies

A pharmacist-led disease management program

Rothman et al.38 established a clinical pharmacist team within a primary care clinic that provided patient education, case management, and medication management to diabetic patients. This randomized trial was conducted from February 2001 to April 2003 at an academic general internal medicine practice staffed by attending faculty and residents. Participating patients, recruited by primary care provider referral (n = 217), were adults with type 2 diabetes who had an A1C result > 8.0%.

Patients were randomized to an intervention group or a control group. Those assigned to the control condition received a single management session from a clinical pharmacist followed by usual care from their primary care provider. The intervention group received a variety of services coordinated by three clinical pharmacists and a case manager within the general internal medicine practice. After receiving training in outpatient diabetes management (two became certified diabetes educators), they executed the program, which was supplemental to the patients’ usual primary care visits.

Pharmacists had contact with the patients every 2–4 weeks by phone or in person. Individualized counseling and education and medication management were provided according to evidence-based algorithms. The algorithms were developed with input from clinic physicians and approved by the clinic’s leadership. Primary care providers were notified of the results of these sessions. Additionally, the care coordinator contacted patients regularly to remind them about appointments, identify barriers to care, and address treatment adherence.

Primary care providers could choose whether they wanted to receive medication adjustment recommendations from the pharmacists or be notified after the changes had been made. Proactive management of clinical parameters was facilitated by regular review of an electronic patient database. Patients whose blood pressure was uncontrolled, for example, were identified and targeted for further medication intensification.

After 12 months of follow-up, multiple key indicators improved significantly. Control patients’ mean A1C improved by 1.6% compared to 2.5% among intervention patients (difference 0.8%; 95% CI 0.0–1.7). Both systolic and diastolic blood pressure improved more among intervention than control patients. From baseline to 12 months of follow-up, control patients had an increase of 2 mmHg in systolic blood pressure, whereas intervention patients had a decrease of 7 mmHg (difference 9 mmHg; 95% CI 3–11). Diastolic blood pressure increased 1 mmHg in control patients compared to a decrease of 4 mmHg in the intervention group (difference 5 mmHg; 95% CI 1–9). Aspirin use for cardiovascular risk reduction was also significantly higher among intervention patients. Total cholesterol improved more in the intervention group, but the difference was modest and did not reach statistical significance.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Summary of Quality Improvement Strategies

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2.

Summary of Recent Review Articles and Meta-Analyses on Nurses or Pharmacists Caring for Diabetic Patients in Collaboration With Physicians*

Labor and cost analyses of the program showed that the additional personnel resources came at a moderately increased expense.39 Patient care–related activities such as visits, phone calls, or medical chart reviews occurred more often for the intervention group (mean 4 vs. 1.1 times per month) and more time was spent (38.6 vs. 10.7 minutes per month) (P < 0.001 for both). Among intervention patients, 46% of this time was spent for in-person contact, 42% for telephone management, and 11% for medical chart review, appointment setting, and other activities.

The costs associated with the program were modest compared to most modern medical interventions. The labor and indirect costs for the intervention group were $47.21 per patient per month versus $10.23 for the control group. The marginal costs of implementing the program were $36.97 per patient per month. Possible cost savings resulting from potential reductions in emergency department or hospital utilization were not assessed.

This model could function with clinical pharmacists or nurses within a single clinic or, to spread the cost burden, as an adjunct program that supports patients from multiple practices. A pharmacist-led disease management program that increases opportunities for patient education, case management, and medication management can efficiently improve diabetes outcomes at a reasonable cost.

An advanced practice nurse–physician team model

By creating structured care processes, primary care physicians and nurse practitioners working in teams can improve both diabetes patient care and clinical outcomes. Litaker et al.29 studied clinical processes, outcomes, and costs in a randomized, controlled trial from October 1996 to January 1998. Nurse practitioner–primary care physician (NP-MD) teams managed patients with both hypertension and diabetes. One hundred and fifty-seven patients with mild to moderate hypertension and diabetes managed without insulin were identified by providers or responded to advertisements at this academic institution.

Participants were randomized to an intervention group managed by the NP-MD team or a control group managed as usual by their primary care physician. In the intervention group, the nurse practitioners were established as the first-line contact for care and followed evidence-based algorithms to guide independent management decisions. They engaged in disease management via phone contact with patients and in-office follow-up appointments. If problems arose that were not addressed in the algorithms, the nurses discussed them with the patients’ primary care physician and a treatment plan was established. New chart forms were implemented to facilitate preventive care. The nurses addressed patient education and psychosocial barriers to adherence and also developed treatment regimens that incorporated patient preferences.

During 12 months, nurse practitioner and physician team care was successful in improving delivery of preventive care, patient education, and A1C values. Nine of eleven measures of these domains showed statistically significant differences between the two groups (all P < 0.001). For example, comparing team care to usual care, influenza vaccination (78 vs. 47%), foot exam (100 vs. 36%), smoking cessation (100 vs. 20%), and weight control (100 vs. 76%) were all conducted for more patients in the intervention group per guidelines. Only measures of eye exams by an ophthalmologist (78 vs. 68%, P = 0.10) and medication adherence (100 vs. 95%, P = 0.06) did not show significant differences.

Physiological parameters showed mixed but promising results. Greater improvements in A1C were seen in the intervention group compared to the usual care group (−0.63 vs. −0.15%, P = 0.02). Total cholesterol and the percentage of patients with blood pressure under control were not significantly different between groups. Notably, at 12 months after study completion, A1C values were trending back toward baseline levels, indicating that the team care may need to be continued throughout patients’ chronic illness to sustain the benefits.

The researchers predicted that the personnel costs for 12 months would be reduced by shifting the locus of care from physicians to nurse practitioners. However, the cost per patient for 1 year was higher in the team care than in the usual care group ($134.68 vs. $93.70, P < 0.001). A retrospective chart review revealed that, because of the additional care of the nurse practitioner, team care patients had a significantly greater average amount of time spent during 12 months for management of hypertension or diabetes (180 vs. 85 minutes, P < 0.001). This increased time likely offset the lower labor cost of the nurses relative to the physicians.

Notably, patient satisfaction was significantly higher in the intervention group. Although this program accrued additional expenses over usual care, it did demonstrate that advanced practice nurses working in collaboration with primary care physicians to deliver algorithm-based diabetes care can improve A1C and patient satisfaction levels, as well as other important prevention and clinical outcomes.

Discussion

To achieve broad acceptance, programs such as these may need to offset expenses through savings generated by reduced health care utilization. This will require new payment models that reward cost-effective practice in primary care. Numerous studies have now demonstrated that improving diabetes control can reduce complications and likely reduce costs. Reduction in the risk of complications can lower the health care system or societal expense associated with diabetes.40 For example, in one evaluation of diabetes costs at a health maintenance organization that implemented enhanced diabetes management,41 patients whose baseline A1C was > 10% and improved by ≥ 1% generated a mean savings of $820 in health care costs for each year during a 4-year period. In a separate pharmacist-run diabetes management program, average A1C fell from 9.5% at baseline to 7.8% after 1 year,42 with a total cost avoidance from this benefit calculated to be $59,040.41,42

Primary care providers who are eager to adopt models of team care may therefore be able to justify the added costs if the savings can be captured within a single larger organization. Financial models such as the Accountable Care Organization and Patient-Centered Medical Home models that could reward care coordination, quality improvement, and more cost-effective services are under study by both the Centers for Medicare and Medicaid Services and private insurers.43,44 Intensified care, possibly through coordination with nurses and clinical pharmacists, is not only efficacious, but may also prove to be cost-effective for meeting the rising demand for diabetes care.

Multiple training opportunities exist for nurses and clinical pharmacists who wish to specialize in caring for diabetic patients. Primary care practices may wish to specifically seek candidates with specialized training when implementing team-based diabetes programs. Clinical pharmacists have typically received doctorate of pharmacy degrees and then elected to complete post-graduate residency training programs, which open more opportunities to care for patients directly. To further specialize, clinical pharmacists can opt to complete a second post-graduate residency year (PGY2) in their preferred area. PGY2 residencies are available in multiple practice areas, including ambulatory care, cardiology, internal medicine, and pharmacotherapy.45 Pharmacists can also attain certification in various areas of expertise. The Board of Pharmacy Specialties offers certifications in both pharmacotherapy and ambulatory care pharmacy that provide skills for outpatient diabetes management.46

Specifically for certifications in diabetes, multiple disciplines including pharmacists and registered nurses can become certified diabetes educators (CDEs) through the National Certification Board for Diabetes Educators. This training provides specialized knowledge in diabetes self-management education and training (DSME/T), which is a core component of the diabetes comprehensive care plan. It facilitates the knowledge, skill, and ability necessary for self-care by supporting informed decision-making, problem-solving, and collaboration with the care team.47 To become a CDE, candidates must have experience in their respective discipline, as well as 1,000 hours of DSME/T experience.48 Pharmacists and advanced practice nurses have also been eligible for board certification in advanced diabetes management, although this certification is currently under review.49

Conclusions

The field of primary care faces substantial challenges in transforming itself to meet the rising tide of diabetes and other chronic illnesses. Team care that used the unique training of pharmacists and nurses in medication management and individualized case management in coordination with the medical expertise of primary care physicians will be a powerful tool to address these needs.

As the nurse and clinical pharmacist workforces broaden their scopes, the Chronic Care Model and Patient-Centered Medical Home concept can come closer to achieving more comprehensive chronic disease management in primary care.50 Both systems are designed around multidisciplinary care teams, and both address barriers at the system, community, patient, and provider levels.51 Additionally, models have been put forth that detail how such systems might be adapted for team approaches to diabetes care.52,53

These innovative systems will lay the groundwork for making team approaches to diabetes care more feasible in community practices and health systems. As our patients demand that we shift from treating mostly acute illnesses to managing chronic diseases, teams of providers working collaboratively at the top of their skill sets can best meet patients’ complex needs.

Footnotes

  • All of the authors are based in Nashville, Tenn. David Willens, MD, is a Veterans Administration (VA) Quality Scholars Fellow, and Rebecca Cripps, PharmD, and Amy Wilson, PharmD, are clinical pharmacy specialists at the VA Tennessee Valley Health System. Kathleen Wolff, MSN, APRN, BC-FNP, is a diabetes nurse practitioner at the Vanderbilt University Medical Center Eskind Diabetes Clinic. Russell Rothman, MD, MPP, is an associate professor of internal medicine and pediatrics; chief of the Internal Medicine and Pediatrics section; and director of the Vanderbilt Program in Effective Health Communication at the Vanderbilt University Medical Center.

  • American Diabetes Association(R) Inc., 2011

REFERENCES

  1. ↵
    1. Centers for Disease Control and Prevention
    : National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, Ga., U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008
  2. ↵
    1. Narayan KM,
    2. Boyle JP,
    3. Geiss LS,
    4. Saaddine JB,
    5. Thompson TJ
    : Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care 29:2114–2116, 2006
    OpenUrlFREE Full Text
  3. ↵
    1. Nathan DM,
    2. Cleary PA,
    3. Backlund JY,
    4. Genuth SM,
    5. Lachin JM,
    6. Orchard TJ,
    7. Raskin P,
    8. Zinman B
    : Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643–2653, 2005
    OpenUrlCrossRefPubMedWeb of Science
    1. Stratton IM,
    2. Adler AI,
    3. Neil HA,
    4. Matthews DR,
    5. Manley SE,
    6. Cull CA,
    7. Hadden D,
    8. Turner RC,
    9. Holman RR
    : Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412, 2000
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Grundy SM,
    2. Cleeman JI,
    3. Merz CN,
    4. Brewer HB Jr.,
    5. Clark LT,
    6. Hunninghake DB,
    7. Pasternak RC,
    8. Smith SC Jr.,
    9. Stone NJ
    : Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol 44:720–732, 2004
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. American Diabetes Association
    : Standards of medical care in diabetes—2011. Diabetes Care 34 (Suppl. 1):S11–S61, 2011
    OpenUrlFREE Full Text
  6. ↵
    1. McGlynn EA,
    2. Asch SM,
    3. Adams J,
    4. Keesey J,
    5. Hicks J,
    6. DeCristofaro A,
    7. Kerr EA
    : The quality of health care delivered to adults in the United States. N Engl J Med 348:2635–2645, 2003
    OpenUrl
    1. Hoerger TJ,
    2. Segel JE,
    3. Gregg EW,
    4. Saaddine JB
    : Is glycemic control improving in U.S. adults? Diabetes Care 31:81–86, 2008
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Davidson MB
    : The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review. Curr Diabetes Rev 3:280–286, 2007
    OpenUrlCrossRefPubMed
  8. ↵
    1. Saadine JB,
    2. Fong DS,
    3. Yao J
    : Factors associated with follow-up eye examinations among persons with diabetes. Retina 28:195–200, 2008
    OpenUrlCrossRefPubMed
  9. ↵
    1. Roumie CL,
    2. Elasy TA,
    3. Wallston KA,
    4. Pratt S,
    5. Greevy RA,
    6. Liu X,
    7. Alvarez V,
    8. Dittus RS,
    9. Speroff T
    : Clinical inertia: a common barrier to changing provider prescribing behavior. Jt Comm J Qual Patient Saf 33:277–285, 2007
    OpenUrlPubMed
    1. Brown JB,
    2. Nichols GA
    : Slow response to loss of glycemic control in type 2 diabetes mellitus. Am J Manag Care 9:213–217, 2003
    OpenUrlPubMedWeb of Science
  10. ↵
    1. Phillips LS,
    2. Branch WT,
    3. Cook CB,
    4. Doyle JP,
    5. El-Kebbi IM,
    6. Gallina DL,
    7. Miller CD,
    8. Ziemer DC,
    9. Barnes CS
    : Clinical inertia. Ann Intern Med 135:825–834, 2001
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Lobach DF,
    2. Hammond WE
    : Computerized decision support based on a clinical practice guideline improves compliance with care standards. Am J Med 102:89–98, 1997
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Davidson MB
    : How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care 32:370–372, 2009
    OpenUrlFREE Full Text
  13. ↵
    1. Institute of Medicine
    : The Future of Nursing: Leading Change, Advancing Health. Washington, D.C., National Academies Press, 2011
  14. ↵
    1. Laurant M,
    2. Reeves D,
    3. Hermens R,
    4. Braspenning J,
    5. Grol R,
    6. Sibbald B
    : Substitution of doctors by nurses in primary care. Cochrane Database Syst Rev. 2004. Available online from http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD001271/frame.html
  15. ↵
    1. Bunting BA,
    2. Smith BH,
    3. Sutherland SE
    : The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc (2003) 48:23–31, 2008
    OpenUrlCrossRefPubMedWeb of Science
    1. Bunting BA,
    2. Cranor CW
    : The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003) 46:133–147, 2006
    OpenUrlCrossRefWeb of Science
  16. ↵
    1. Cranor CW,
    2. Bunting BA,
    3. Christensen DB
    : The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 43:173–184, 2003
    OpenUrlCrossRefPubMed
  17. ↵
    1. Katon WJ,
    2. Lin EH,
    3. Von Korff M,
    4. Ciechanowski P,
    5. Ludman EJ,
    6. Young B,
    7. Peterson D,
    8. Rutter CM,
    9. McGregor M,
    10. McCulloch D
    : Collaborative care for patients with depression and chronic illnesses. N Engl J Med 363:2611–2620, 2010
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Group TCM-CTDS
    : Closing the gap: effect of diabetes case management on glycemic control among low-income ethnic minority populations: the California MediCal type 2 diabetes study. Diabetes Care 27:95–103, 2004
    OpenUrlAbstract/FREE Full Text
    1. Aubert RE,
    2. Herman WH,
    3. Waters J,
    4. Moore W,
    5. Sutton D,
    6. Peterson BL,
    7. Bailey CM,
    8. Koplan JP
    : Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization: a randomized, controlled trial. Ann Intern Med 129:605–612, 1998
    OpenUrlCrossRefPubMedWeb of Science
    1. Choe HM,
    2. Mitrovich S,
    3. Dubay D,
    4. Hayward RA,
    5. Krein SL,
    6. Vijan S
    : Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 11:253–260, 2005
    OpenUrlPubMedWeb of Science
    1. Gabbay RA,
    2. Lendel I,
    3. Saleem TM,
    4. Shaeffer G,
    5. Adelman AM,
    6. Mauger DT,
    7. Collins M,
    8. Polomano RC
    : Nurse case management improves blood pressure, emotional distress and diabetes complication screening. Diabetes Res Clin Pract 71:28–35, 2006
    OpenUrlCrossRefPubMedWeb of Science
    1. Gary TL,
    2. Batts-Turner M,
    3. Yeh HC,
    4. Hill-Briggs F,
    5. Bone LR,
    6. Wang NY,
    7. Levine DM,
    8. Powe NR,
    9. Saudek CD,
    10. Hill MN,
    11. McGuire M,
    12. Brancati FL
    : The effects of a nurse case manager and a community health worker team on diabetic control, emergency department visits, and hospitalizations among urban African Americans with type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med 169:1788–1794, 2009
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Loveman E,
    2. Royle P,
    3. Waugh N
    : Specialist nurses in diabetes mellitus. Cochrane Database Syst Rev. CD003286, 2003
    1. Legorreta AP,
    2. Peters AL,
    3. Ossorio RC,
    4. Lopez RJ,
    5. Jatulis D,
    6. Davidson MB
    : Effect of a comprehensive nurse-managed diabetes program: an HMO prospective study. Am J Manag Care 2:1024–1030, 1996
    OpenUrl
  20. ↵
    1. Litaker D,
    2. Mion L,
    3. Planavsky L,
    4. Kippes C,
    5. Mehta N,
    6. Frolkis J
    : Physiciannurse practitioner teams in chronic disease management: the impact on costs, clinical effectiveness, and patients’ perception of care. J Interprof Care 17:223–237, 2003
    OpenUrlCrossRefPubMed
    1. Shea S,
    2. Weinstock RS,
    3. Starren J,
    4. Teresi J,
    5. Palmas W,
    6. Field L,
    7. Morin P,
    8. Goland R,
    9. Izquierdo RE,
    10. Wolff LT,
    11. Ashraf M,
    12. Hilliman C,
    13. Silver S,
    14. Meyer S,
    15. Holmes D,
    16. Petkova E,
    17. Capps L,
    18. Lantigua RA
    : A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc 13:40–51, 2006
    OpenUrlAbstract/FREE Full Text
    1. Shea S,
    2. Weinstock RS,
    3. Teresi JA,
    4. Palmas W,
    5. Starren J,
    6. Cimino JJ,
    7. Lai AM,
    8. Field L,
    9. Morin PC,
    10. Goland R,
    11. Izquierdo RE,
    12. Ebner S,
    13. Silver S,
    14. Petkova E,
    15. Kong J,
    16. Eimicke JP
    : A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. J Am Med Inform Assoc 16:446–456, 2009
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Shojania KG,
    2. Ranji SR,
    3. McDonald KM,
    4. Grimshaw JM,
    5. Sundaram V,
    6. Rushakoff RJ,
    7. Owens DK
    : Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 296:427–440, 2006
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Welch G,
    2. Garb J,
    3. Zagarins S,
    4. Lendel I,
    5. Gabbay RA
    : Nurse diabetes case management interventions and blood glucose control: results of a meta-analysis. Diabetes Res Clin Pract 88:1–6, 2010
    OpenUrlCrossRefPubMed
  23. ↵
    1. Chisholm-Burns MA,
    2. Kim Lee J,
    3. Spivey CA,
    4. Slack M,
    5. Herrier RN,
    6. Hall-Lipsy E,
    7. Graff Zivin J,
    8. Abraham I,
    9. Palmer J,
    10. Martin JR,
    11. Kramer SS,
    12. Wunz T
    : U.S. pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care 48:923–933, 2010
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Machado M,
    2. Bajcar J,
    3. Guzzo GC,
    4. Einarson TR
    : Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother 41:1569–1582, 2007
    OpenUrlCrossRefPubMedWeb of Science
    1. Saxena S,
    2. Misra T,
    3. Car J,
    4. Gopalakrishnan N,
    5. Smith R,
    6. Majeed A
    : Systematic review of primary healthcare interventions to improve diabetes outcomes in minority ethnic groups. J Ambul Care Manag 30:218–230, 2007
    OpenUrlPubMed
  25. ↵
    1. Wubben DP,
    2. Vivian EM
    : Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy 28:421–436, 2008
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Rothman RL,
    2. Malone R,
    3. Bryant B,
    4. Shintani AK,
    5. Crigler B,
    6. Dewalt DA,
    7. Dittus RS,
    8. Weinberger M,
    9. Pignone MP
    : A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 118:276–284, 2005
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Rothman RL,
    2. So SA,
    3. Shin J,
    4. Malone RM,
    5. Bryant B,
    6. Dewalt DA,
    7. Pignone MP,
    8. Dittus RS
    : Labor characteristics and program costs of a successful diabetes disease management program. Am J Manag Care 12:277–283, 2006
    OpenUrlPubMedWeb of Science
  28. ↵
    1. U.K. Prospective Diabetes Study Group
    : Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Wagner EH,
    2. Sandhu N,
    3. Newton KM,
    4. McCulloch DK,
    5. Ramsey SD,
    6. Grothaus LC
    : Effect of improved glycemic control on health care costs and utilization. JAMA 285:182–189, 2001
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    1. Ragucci KR,
    2. Fermo JD,
    3. Wessell AM,
    4. Chumney EC
    : Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy 25:1809–1816, 2005
    OpenUrlCrossRefPubMedWeb of Science
  31. ↵
    1. Landon BE,
    2. Schneider EC,
    3. Normand SL,
    4. Scholle SH,
    5. Pawlson LG,
    6. Epstein AM
    : Quality of care in Medicaid managed care and commercial health plans. JAMA 298:1674–1681, 2007
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Rosenthal TC
    : The medical home: growing evidence to support a new approach to primary care. J Am Board Fam Med 21:427–440, 2008
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. American Society of Health-System Pharmacists
    : The next step: PGY2 residencies [articlel online]. Available from http://www.ashp.org/Import/ACCREDITATION/ResidentInfo/NextStep.aspx. Accessed 9 January 2011
  34. ↵
    1. Board of Pharmacy Specialties
    : Current specialties [article online]. Available from http://www.bpsweb.org/specialties/specialties.cfm. Accessed 9 January 2011
  35. ↵
    1. Funnell MM,
    2. Brown TL,
    3. Childs BP,
    4. Haas LB,
    5. Hosey GM,
    6. Jensen B,
    7. Maryniuk M,
    8. Peyrot M,
    9. Piette JD,
    10. Reader D,
    11. Siminerio LM,
    12. Weinger K,
    13. Weiss MA
    : National standards for diabetes self-management education. Diabetes Care 33 (Suppl. 1):S89–S96, 2010
    OpenUrlFREE Full Text
  36. ↵
    National Certification Board for Diabetes Educators. Home page. Available from http://www.ncbde.org. Accessed 6 February 2011
  37. ↵
    1. American Association of Diabetes Educators
    : Board-Certified Advanced Diabetes Management [article online]. Available from http://www.diabeteseducator.org/ProfessionalResources/Certification/BC-ADM. Accessed 9 January 2011
  38. ↵
    1. Coleman K,
    2. Austin BT,
    3. Brach C,
    4. Wagner EH
    : Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood) 28:75–85, 2009
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Bodenheimer T,
    2. Wagner EH,
    3. Grumbach K
    : Improving primary care for patients with chronic illness: the Chronic Care Model, Part 2. JAMA 288:1909–1914, 2002
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Cavanaugh KL,
    2. White RO,
    3. Rothman RL
    : Exploring disease management programs for diabetes mellitus: proposal of a novel hybrid model. Dis Manag Health Outcomes 15:73–81, 2007
    OpenUrlCrossRef
  41. ↵
    1. Brown AW,
    2. Wolff KL,
    3. Elasy TA,
    4. Graber AL
    : The role of advanced practice nurses in a shared care diabetes practice model. Diabetes Educ 27:492–496, 498–500, 502, 2001
    OpenUrlFREE Full Text
    1. Shojania KG,
    2. McDonald KM,
    3. Wachter RM,
    4. Owens DK
    : Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies, Volume 1—Series Overview and Methodology. AHRQ Publication No. 04-0051-1. Rockville, Md., Agency for Healthcare Research and Quality, 2004
PreviousNext
Back to top
Clinical Diabetes: 29 (2)

In this Issue

April 2011, 29(2)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Clinical Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Interdisciplinary Team Care for Diabetic Patients by Primary Care Physicians, Advanced Practice Nurses, and Clinical Pharmacists
(Your Name) has forwarded a page to you from Clinical Diabetes
(Your Name) thought you would like to see this page from the Clinical Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Interdisciplinary Team Care for Diabetic Patients by Primary Care Physicians, Advanced Practice Nurses, and Clinical Pharmacists
David Willens, Rebecca Cripps, Amy Wilson, Kathleen Wolff, Russell Rothman
Clinical Diabetes Apr 2011, 29 (2) 60-68; DOI: 10.2337/diaclin.29.2.60

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Interdisciplinary Team Care for Diabetic Patients by Primary Care Physicians, Advanced Practice Nurses, and Clinical Pharmacists
David Willens, Rebecca Cripps, Amy Wilson, Kathleen Wolff, Russell Rothman
Clinical Diabetes Apr 2011, 29 (2) 60-68; DOI: 10.2337/diaclin.29.2.60
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • IN BRIEF
    • Case Studies
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • “Counting Carbs to Be in Charge”: A Comparison of an Internet-Based Education Module With In-Class Education in Adolescents With Type 1 Diabetes
  • Improving Diabetes Control Using Lean Six Sigma Quality Improvement in an Endocrine Clinic in a Large Accountable Care Organization
  • Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence
Show more Feature Articles

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Abridged Standards of Care
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.